Search Orphan Drug Designations and Approvals
-
Generic Name: | human insulin (rDNA) |
---|---|
Date Designated: | 04/06/2015 |
Orphan Designation: | Treatment of short bowel syndrome (SBS). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ELGAN Pharma Ltd. 13 wadi el hadj Nazareth 17111 Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-